Retrospective comparison of caffeine and doxapram for the treatment of hypercapnia in foals with hypoxic-ischemic encephalopathy.

This research paper compares the efficacy of caffeine and doxapram in treating high carbon dioxide levels in the blood of foals affected by brain damage due to lack of oxygen. The findings suggest that doxapram is more effective in rapidly reducing these levels.

Objective and Methodology

The main goal of this research was to assess and compare the effectiveness of two drugs, caffeine and doxapram, in treating hypercapnia (excessive carbon dioxide in the bloodstream) in foals suffering from hypoxic-ischemic encephalopathy, a type of brain damage caused by lack of oxygen. For this purpose, sixteen foals, divided into two groups of eight, were treated with either of these drugs.

• Important factors such as age, body temperature, heart rate, respiratory rate, arterial blood gas parameters, duration of therapy, and outcome were recorded from each medical case.

Results

Following the treatment:

• Those foals who were treated with doxapram showed a significant decrease in the partial pressure of carbon dioxide, bicarbonate concentration, and base excess – a measurement of the amount of acid/base in the body. However, this drug did not succeed in correcting acidemia, an abnormally high acidity of the blood.
• On the other hand, the administration of caffeine did not show substantial changes from the baseline values.
• The percentage reduction in carbon dioxide partial pressure and bicarbonate concentration was notably greater in foals treated with doxapram as compared to those treated with caffeine.
• The number of foals that achieved the target carbon dioxide partial pressure levels was significantly higher in the group treated with doxapram.
• The survival rates were not significantly different between the two groups.

Conclusion

Based on these findings, the researchers concluded that doxapram appears to be more efficient than caffeine in promptly correcting hypercapnia in foals with hypoxic-ischemic encephalopathy. However, it should be noted that this does not imply an increase in survival rates, as no significant difference was observed between the two groups in terms of survival.